GoodRx Holdings, Inc. GDRX
Our mission is to help Americans save time and money when filling their medications. To achieve this, we are building
the leading, consumer-focused digital healthcare platform in the United States.
healthcare by removing the friction and inefficiencies in the system. We started with a price comparison tool for
prescriptions, offering consumers free access to lower prices on their medication. This price comparison platform processes
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $796.9M | $792.3M | $750.3M | $766.6M | $745.4M | $550.7M | $388.2M | $249.5M | — |
| R&D | $121.0M | $123.7M | $135.8M | $143.1M | $125.9M | $61.8M | $29.3M | $43.9M | — |
| SG&A | $114.0M | $117.9M | $125.5M | $144.8M | $154.7M | $461.5M | $14.7M | $8.4M | — |
| Total operating expenses | $709.4M | $726.5M | $777.3M | $764.8M | $732.0M | $826.4M | $248.5M | $172.3M | — |
| Operating income | $87.5M | $65.8M | -$27.0M | $1.7M | $13.4M | -$275.7M | $139.7M | $77.3M | — |
| Interest expense | $42.6M | $52.9M | $56.7M | $34.2M | — | — | — | — | — |
| Pre-tax income | $56.5M | $31.5M | -$55.6M | -$23.2M | -$10.2M | -$303.4M | $83.0M | $52.3M | — |
| Income tax | $26.1M | $15.1M | $46.7M | $9.6M | $15.1M | $9.8M | $16.9M | $8.6M | — |
| Net income | $30.4M | $16.4M | -$8.9M | -$32.8M | -$25.3M | -$293.6M | $66.0M | $43.8M | — |
| EPS, basic | 0.09 | 0.04 | -0.02 | -0.08 | -0.06 | -1.07 | 0.19 | 0.12 | — |
| EPS, diluted | 0.09 | 0.04 | -0.02 | -0.08 | -0.06 | -1.07 | 0.18 | 0.12 | — |
| Shares, diluted (wtd. avg.) | 357.0M | 392.2M | 410.3M | 412.9M | 410.0M | 274.7M | 231.2M | 118.3M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $261.8M | $448.3M | $672.3M | $757.2M | $941.1M | $968.7M | $26.1M | $34.6M | — |
| Receivables | $235.7M | $145.9M | $143.6M | $117.1M | $118.1M | $68.7M | $48.1M | — | — |
| Total current assets | $643.1M | $659.3M | $872.8M | $919.7M | $1.09B | $1.09B | $86.6M | — | — |
| Property, plant and equipment | $12.3M | $12.7M | $15.9M | $19.8M | $21.6M | $23.1M | $1.9M | — | — |
| Goodwill | $430.3M | $410.8M | $410.8M | $412.1M | $329.7M | $261.1M | $236.2M | $220.4M | — |
| Other intangibles | $64.1M | $52.1M | $60.9M | $119.9M | $88.8M | $36.9M | $21.3M | — | — |
| Total assets | $1.40B | $1.39B | $1.59B | $1.60B | $1.61B | $1.47B | $386.8M | — | — |
| Accounts payable | $19.4M | $14.1M | $36.3M | $17.7M | $17.5M | $10.3M | $7.9M | — | — |
| Short-term debt | $5.0M | $5.0M | $8.8M | $7.0M | $7.0M | $7.0M | $7.0M | — | — |
| Total current liabilities | $246.0M | $123.9M | $122.6M | $76.3M | $81.1M | $59.6M | $33.4M | — | — |
| Long-term debt | $483.3M | $486.7M | $647.7M | $651.8M | $655.9M | $659.9M | $663.9M | — | — |
| Total liabilities | $787.8M | $663.4M | $826.8M | $789.8M | $775.9M | $758.8M | $737.4M | — | — |
| Retained earnings | -$1.41B | -$1.44B | -$1.46B | -$1.45B | -$1.42B | -$1.39B | -$1.10B | — | — |
| Total equity | $616.3M | $724.7M | $762.0M | $814.8M | $831.7M | $711.4M | -$1.09B | -$1.16B | -$31.8M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $167.9M | $183.9M | $138.3M | $146.8M | $178.8M | $131.3M | $83.3M | $45.3M | — |
| Depreciation and amortisation | $4.2M | $4.5M | $4.8M | $4.6M | $4.0M | $1.4M | $700.0K | $300.0K | — |
| Stock-based compensation | $76.6M | $99.0M | $104.8M | $120.2M | $160.5M | $397.3M | $3.7M | $1.8M | — |
| Capital expenditure | $3.5M | $1.2M | $1.0M | $4.0M | $4.6M | $20.6M | $1.4M | $804.0K | — |
| Investing cash flow | -$120.0M | -$70.3M | -$55.8M | -$210.5M | -$178.7M | -$91.6M | -$37.1M | -$3.5M | — |
| Financing cash flow | -$234.5M | -$337.5M | -$167.4M | -$120.2M | -$30.5M | $905.8M | -$54.8M | -$24.7M | — |
| Dividends paid | — | — | — | — | — | — | — | $1.35B | — |
| Buybacks | $216.4M | $158.8M | $104.0M | $101.7M | $0 | $0 | — | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001809519-26-000091.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $249.5M | $388.2M | $550.7M | $745.4M | $766.6M | $750.3M | $792.3M | $796.9M |
| Gross profit | — | — | — | — | — | — | — | — | — |
| Net income | — | $43.8M | $66.0M | -$293.6M | -$25.3M | -$32.8M | -$8.9M | $16.4M | $30.4M |
Recent filings and events
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Results announced Item 2.02
- Officer or director change Item 5.02
- Officer or director change Item 5.02
- Officer or director change Item 5.02
- Auditor changed The company changed auditors. Sometimes routine; historically one of the more reliable warnings that something is wrong. Item 4.01
- Officer or director change Item 5.02
- Officer or director change Item 5.02
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Results announced Item 2.02
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 7374
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| ADP | AUTOMATIC DATA PROCESSING INC | $120.83B | 27.8x | 6.7% |
| WDAY | Workday, Inc. | $51.49B | 81.1x | 13.1% |
| RDDT | Reddit, Inc. | $27.75B | 55.1x | 69.4% |
| VRSK | Verisk Analytics, Inc. | $25.66B | 30.2x | 6.6% |
| TOST | Toast, Inc. | $18.91B | 58.4x | 24.1% |
| HNGE | Hinge Health, Inc. | $8.81B | — | 50.6% |
| RNG | RingCentral, Inc. | $7.01B | 173.7x | 4.8% |
| PEGA | PEGASYSTEMS INC | $5.99B | 17.1x | 16.6% |